EXEMESTANE

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 59762-2858
  • Package NDC 59762-2858-1
  • Application number NDA020753
  • SPL ID 6aeb23c4-3f3f-4966-829c-12e7e6ec91ef
  • SPL set ID 69abd0ff-b200-4d1a-b14a-80e980a8e781
  • UNII NY22HMQ4BX
  • RxCUI 310261

What the source publishes

Labeler
Mylan Pharmaceuticals Inc.
Active ingredients
Exemestane
Form
TABLET, SUGAR COATED
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
NDA AUTHORIZED GENERIC
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:59762-2858_6aeb23c4-3f3f-4966-829c-12e7e6ec91ef
{
  "name": "EXEMESTANE",
  "splId": "6aeb23c4-3f3f-4966-829c-12e7e6ec91ef",
  "labels": [
    {
      "setId": "69abd0ff-b200-4d1a-b14a-80e980a8e781",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=69abd0ff-b200-4d1a-b14a-80e980a8e781",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=69abd0ff-b200-4d1a-b14a-80e980a8e781"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Mylan Pharmaceuticals Inc.",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "30 TABLET, SUGAR COATED in 1 BOTTLE (59762-2858-1)",
      "package_ndc": "59762-2858-1",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20110401"
    }
  ],
  "productId": "59762-2858_6aeb23c4-3f3f-4966-829c-12e7e6ec91ef",
  "useDomain": "unknown",
  "dosageForm": "TABLET, SUGAR COATED",
  "productNdc": "59762-2858",
  "deaSchedule": null,
  "genericName": "Exemestane",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "EXEMESTANE",
      "strength": "25 mg/1"
    }
  ],
  "applicationNumber": "NDA020753",
  "marketingCategory": "NDA AUTHORIZED GENERIC",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20110401",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000175563",
      "N0000175080"
    ],
    "upc": [
      "0359762285812"
    ],
    "unii": [
      "NY22HMQ4BX"
    ],
    "rxcui": [
      "310261"
    ],
    "spl_set_id": [
      "69abd0ff-b200-4d1a-b14a-80e980a8e781"
    ],
    "pharm_class_epc": [
      "Aromatase Inhibitor [EPC]"
    ],
    "pharm_class_moa": [
      "Aromatase Inhibitors [MoA]"
    ],
    "manufacturer_name": [
      "Mylan Pharmaceuticals Inc."
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:59762-2858_6aeb23c4-3f3f-4966-829c-12e7e6ec91ef"